+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioresorbable Stents - Global Market Trajectory & Analytics

  • ID: 4804736
  • Report
  • May 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterius Ltd.
  • Biotronik SE & Co. KG
  • OrbusNeich
  • Qualimed

Global Bioresorbable Stents Market to Reach $691.6 Million by 2027


Amid the COVID-19 crisis, the global market for Bioresorbable Stents estimated at US$316.7 Million in the year 2020, is projected to reach a revised size of US$691.6 Million by 2027, growing at a CAGR of 11% over the analysis period 2021-2027. Polymer-based Bioresorbable Stents, one of the segments analyzed in the report, is projected to reach US$499.5 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metal-based Bioresorbable Stents segment is readjusted to a revised 10% CAGR for the next 7-year period.

European Market is Estimated at $170.6 Million, While Asia-Pacific is Forecast to Grow at 10.3% CAGR




Bioresorbable Stents market in Europe is estimated at US$170.6 Million in the year 2020. Asia-Pacific is forecast to reach a projected market size of US$176.2 Million by the year 2027 trailing a CAGR of 10.3% over the analysis period 2020 to 2027. Rest of World is forecast to grow at 11.1% over the 2020-2027 period.

Select Competitors (Total 25 Featured) -

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies SA
  • Arterius Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt., Ltd.
  • OrbusNeich
  • Qualimed
  • Reva Medical, Inc.
  • S3V Vascular Technologies Pvt., Ltd.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterius Ltd.
  • Biotronik SE & Co. KG
  • OrbusNeich
  • Qualimed
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Coronary Artery Disease (CAD) - A Perspective
  • Causes and Symptoms
  • Treatment Options for Coronary Artery Disease
  • Percutaneous Coronary Intervention (PCI)
  • Coronary Stenting
  • Types of Coronary Stents
  • Bare Metal Stents (BMS)
  • Drug Eluting Stents (DES)
  • Bioresorbable Stents/Scaffolds
  • Design and Composition of Bioresorbable Stents
  • Different Types of Bioresorbable Stents
  • Metallic Bioresorbable Stents
  • Polymer Bioresorbable Stents
  • Degradation Period of Select Bioabsorbable Materials
  • Challenges
  • Clinical Characteristics of Various Coronary Stents
  • Other Treatment Options for Coronary Heart Disease
  • Coronary Artery Bypass Grafting (CABG)
  • Minimally Invasive Direct Coronary Artery Bypass (MIDCAB)
  • TransMyocardial Laser Revascularization (TMR)
  • Peripheral Arterial Disease: Understanding the Stealthy Peril
  • Treatment for PAD
  • Stenting- A Treatment Option for PAD
  • BioResorbable Stents - A Prelude
  • Bioresorbable Vascular Stents: Advantages and Challenges
  • Bioresorbable Stents - A Revolutionary Technology, Riddled with Controversies
  • Abbott Stops Sales of the Once Promising ‘Absorb' Bioresorbable Stents due to Adverse Events
  • Impact of Abbott's Withdrawal of Absorb on the Bioresorbable Stent Industry
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Impact of COVID - 19 on Coronary Stents Market
  • Impact on Supply Chain
  • Impact of COVID-19 Outbreak on Elective Surgeries
  • Global Bioresorbable Stents Market Buckles under COVID-19 Strain
  • GLOBAL MARKET OVERVIEW
  • Global Bioresorbable Stents Set to Witness Growth in Future
  • Europe Dominates, Asia-Pacific Exhibits Fastest Growth
  • CAD Constitutes the Leading Application
  • Metallic Vs. Polymer-based Stents
  • Bioabsorbable Metallic Stents
  • Bioabsorbable Polymer Stents
  • Disappointing Results by Absorb to Increase Focus on Metallic Stents
  • Availability of Alternative Treatments - Hindrance to Market Growth
  • Market Challenges
  • MARKET OUTLOOK
  • Bioresorbable and Integrated Biosensor Technology to Redefine Future of Vascular Stents
  • The Future of BRS Technology
  • COMPETITION
  • Select Approved Bioresorbable Scaffolds
  • Select Bioresorbable Stents in Pipeline
  • Abbott Revives Bioresorbable Stent Clinical Trials to Evaluate New Esprit Scaffold
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
  • Polymeric Resorbable Scaffolds Hold a Major Market Share
  • The Absorb BRS program
  • Desaminotyrosine Polycarbonate-based BRS
  • The FANTOM program
  • Magnesium-based BRS
  • The Magmaris program
  • Iron-based BRS
  • Global Menace of Coronary Artery Disease (CAD) - A Major Growth Driver
  • EXHIBIT 2: Global Annual Medical Cost of CVD in the United States: 2015-2030
  • EXHIBIT 3: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Ageing Demographics and Longer Life Expectancy Bolsters Market Growth
  • EXHIBIT 4: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • EXHIBIT 5: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Rising Middle Class Population Aids Growth
  • EXHIBIT 6: Global Middle Class Population (in Millions) by Geographic Region: 2010, 2020E & 2030P
  • Rising Healthcare Expenditure: Opportunities in Store
  • EXHIBIT 7: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • EXHIBIT 8: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
  • EXHIBIT 9: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
  • Diabetics at Higher Risk of Heart Diseases
  • EXHIBIT 10: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040
  • The Hypertension-Cholesterol Link to Drive Demand
  • EXHIBIT 11: Hypertension Prevalence (%) Worldwide by Region in Male and Females Aged 25+ Years
  • Metal Bioresorbable scaffolds Exhibit Improved Performance Compared to Polymer Stents
  • Metal Stents Vis-à-Vis Other Stents
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Bioresorbable Stents by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 2: World 7-Year Perspective for Bioresorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • TABLE 3: World Current & Future Analysis for Polymer-based by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 4: World 7-Year Perspective for Polymer-based by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 5: World Current & Future Analysis for Metal-based by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 6: World 7-Year Perspective for Metal-based by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 7: World Current & Future Analysis for Coronary Artery Disease/CAD by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 8: World 7-Year Perspective for Coronary Artery Disease/CAD by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 9: World Current & Future Analysis for Peripheral Artery Disease/PAD by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 10: World 7-Year Perspective for Peripheral Artery Disease/PAD by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 11: World Current & Future Analysis for Hospitals by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 12: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • TABLE 13: World Current & Future Analysis for Cardiovascular Centers by Geographic Region - Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • TABLE 14: World 7-Year Perspective for Cardiovascular Centers by Geographic Region - Percentage Breakdown of Value Sales for Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS

EUROPE
  • TABLE 15: Europe Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 16: Europe 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027
  • TABLE 17: Europe Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 18: Europe 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027
  • TABLE 19: Europe Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 20: Europe 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027
ASIA-PACIFIC
  • TABLE 21: Asia-Pacific Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 22: Asia-Pacific 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027
  • TABLE 23: Asia-Pacific Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 24: Asia-Pacific 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027
  • TABLE 25: Asia-Pacific Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 26: Asia-Pacific 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027
REST OF WORLD
  • TABLE 27: Rest of World Current & Future Analysis for Bioresorbable Stents by Material - Polymer-based and Metal-based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 28: Rest of World 7-Year Perspective for Bioresorbable Stents by Material - Percentage Breakdown of Value Sales for Polymer-based and Metal-based for the Years 2020 & 2027
  • TABLE 29: Rest of World Current & Future Analysis for Bioresorbable Stents by Application - Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 30: Rest of World 7-Year Perspective for Bioresorbable Stents by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease/CAD and Peripheral Artery Disease/PAD for the Years 2020 & 2027
  • TABLE 31: Rest of World Current & Future Analysis for Bioresorbable Stents by End-Use - Hospitals and Cardiovascular Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • TABLE 32: Rest of World 7-Year Perspective for Bioresorbable Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals and Cardiovascular Centers for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 25

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies SA
  • Arterius Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt., Ltd.
  • OrbusNeich
  • Qualimed
  • Reva Medical, Inc.
  • S3V Vascular Technologies Pvt., Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll